Peri-Articular Morphine Injection in Total Knee Arthroplasty

Peri-Articular Morphine Injection in Total Knee Arthroplasty - Peri-Articular Morphine Injection in Total Knee Arthroplasty

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017692

Enrollment

100

Registered

2015-05-27

Start date

2015-05-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients performed total knee arthroplasty

Interventions

patients undergoing TKAs received an intraoperative peri-articular injection with added morphine patients undergoing TKAs received an intraoperative peri-articular injection without added morphine.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients undergoing TKAs with the diagnosis of osteoarthritis and rheumatoid arthritis

Exclusion criteria

Exclusion criteria: patients undergoing revision TKA, patients with surgical history in knees

Design outcomes

Primary

Measure	Time frame
postoperative pain, range of motion, swelling	—

Secondary

Measure	Time frame
WOMAC and adverse events	—

Countries

Japan

Contacts

Public ContactKentaro Iwakiri

Shiraniwa Hospital Joint Arthroplasty Center Department of Orthopaedic Surgery

kenpiecekenpiece@yahoo.co.jp0743-70-0022

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026